Interstitial lung disease constitutes a significant treatment burden in patients with rheumatoid arthritis.

Saved in:
Bibliographic Details
Title: Interstitial lung disease constitutes a significant treatment burden in patients with rheumatoid arthritis.
Authors: Aramaki T; Rheumatic Disease Centre, Sasebo Chuo Hospital, Sasebo, Japan., Kojima K; Rheumatic Disease Centre, Sasebo Chuo Hospital, Sasebo, Japan., Michituji T; Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Takatani A; Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Terada K; Rheumatic Disease Centre, Sasebo Chuo Hospital, Sasebo, Japan., Eguchi K; Rheumatic Disease Centre, Sasebo Chuo Hospital, Sasebo, Japan., Ueki Y; Rheumatic Disease Centre, Sasebo Chuo Hospital, Sasebo, Japan., Iwamoto N; Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Kawakami A; Division of Advanced Preventive Medical Sciences, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Source: Frontiers in medicine [Front Med (Lausanne)] 2026 Apr 09; Vol. 13, pp. 1756931. Date of Electronic Publication: 2026 Apr 09 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2296-858X
DOI:10.3389/fmed.2026.1756931